eric topol glp 1 The list of conditions for which GLP-1 drugs provide benefit independent of weight loss keeps growing. Add psoriatic arthritis #AAD26 @AADskin Mapping the effectiveness and risks

Other GLP-1 drugs like Wegovy and Zepbound were developed and tested specifically for obesity treatment with higher doses optimized for weight management outcomes

Individuals with active gastrointestinal conditionsincluding inflammatory bowel disease (Crohn's disease, ulcerative colitis)should seek medical advice and follow American Gastroenterological Association guidance regarding strain-specific, condition-specific probiotic use

Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T, Diaconescu G, Yim HJ, Heo J, Janczewska E, Wong A, Idriz N, Imamura M, Rizzardini G, Takaguchi K, Andreone P, Arbune M, Hou J, Park SJ, Vata A, Cremer J, Elston R, Luki T, Quinn G, Maynard L, Kendrick S, Plein H, Campbell F, Paff M, Theodore D, B-Clear Study Group

from advertising that its product Amberen is clinically proven to cause substantial weight loss in women over 40

Victims and families deserve accountability, and the legal system provides a path to pursue compensation for medical costs, lost income, and the immense personal toll of these injuries